AHSG and type 2 diabetes mellitus: Fetuin-A seems to be associated with reduced bone catabolism (with an inverse relationship with C-telopeptide) in type 2 diabetes [33], while it is reported to be associated with increased osteoporosis in postmenopausal women [34].